top of page

News

Discover the Latest from CrystarVision

News

AI Writes the Referral and Books the OR — MOHW Unveils 'Healthcare AX' in First Live Demo

June 2, 2026

Product

UWF-FOCUS: Enhancing Macula and Optic Disc Visibility

May 3, 2026

Event

CrystarVision debuts UWF-FOCUS at ARVO 2026

May 2, 2026

News

CrystarVision's Reticare Designated as an Innovative Medical Device by Korea’s MFDS

April 16, 2026

News

Strategic MOU with INFINITT Healthcare

February 5, 2026

크리스타비전 로고

Representative

Su Jeong Song

Business Registration Number

835-87-03137

Address

Head Office: 9F, Ilshin Building, 38 Mapo-daero, Mapo-gu, Seoul, Republic of Korea


Branch Office: B1F, 265 Baekjegobun-ro, Songpa-gu, Seoul, Republic of Korea

Contact

(+82) 02-2001-1963

Reticare is a device that assists with ophthalmic diagnosis and does not replace the direct diagnosis or treatment by a medical professional.
All results must ultimately be reviewed and confirmed by a healthcare provider.
Users are advised to use the information provided by Reticare only as a reference or supplementary material.  We prioritize the protection of patient data and privacy.
All data is processed securely in compliance with relevant privacy regulations.
All content, including images and software on this website, is the property of Crystar Vision and is protected by copyright law. Unauthorized reproduction, distribution, or use is prohibited and may result in legal action without prior consent.

Privacy Policy

© CrystarVision(크리스타비전) All rights reserved.

  • X
  • Instagram
bottom of page